Haematology treatment
The hospital provides treatment and advice for patients with blood clots such as Deep Vein Thrombosis and Pulmonary Embolism. This usually involves treatment with anticoagulant (blood thinning) drugs both on inpatient and outpatient basis. An efficient Anticoagulant Clinic is run at the Hospital for this purpose. Advice on thrombosis prevention (e.g. on long haul flights) and testing for Thrombophilia (thrombotic tendency) is also available.
The hospital is also well equipped for dealing with assessment of potential bleeding problems that may complicate surgery.
There is close supervision of the Pathology Laboratory by a Consultant Haematologist and blood diseases are quickly identified and dealt with. Advice is also provided in resolving Haematological problems which occur during assessment of other medical or surgical conditions such as performance of Bone Marrow biopsies both on an inpatient and outpatient basis.
Venesection (removal of blood on a regular basis) for such conditions as Haemochromatosis (too much iron in the body) and Polycythaemia (overproduction of red blood cells) is also provided.
Services provided include:
Bone marrow aspiration and trephine biopsy
Minor invasive procedure under local anaesthetic for the diagnosis of haematological disorders, evaluation of pyrexias of unknown origin and for the staging of haematological malignancies e.g. lymphoma.
Lumbar puncture and intrathecal chemotherapy
Minor invasive procedure under local anaesthetic. Diagnostic test to exclude meningeal infiltration by leukaemia or lymphoma. Allows instillation of local chemotherapy as therapy or prophylaxis.
Bone marrow transplantation
Surgical procedure under general anaesthetic for the collection of autologous or allogeneic stem cells to enable bone marrow transplantation.
Haemopoietic stem cell transplantation
Treatment option for certain patients with haematological malignancies and some non-haematological disorders. Complex preparatory work up including donor assessment and stem cell collection prior to 4-6 week inpatient admission and post-transplant follow up.